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ABSTRACT
Background: The magnitude and duration of conditioned pain modulation (CPM) likely depends 
on the nature and intensity of the conditioning stimulus (CS).
Aims: The aim of this study was to measure the effect of CS intensity on the duration of CPM 
hypoalgesia.
Methods: In this single-blind, nonrandomized, repeated measures study, we assessed CPM hypoal-
gesia in 20 healthy participants following cold pressor tests (CPT) at 7°C and 12°C. The test stimulus, 
a 60-s heat stimulation, was administered before the CPT and immediately after, and again at 5-min 
intervals until participants’ pain scores returned to pre-CS levels. Two hypoalgesia thresholds were 
used to establish return to pre-CS level: within −10/100 of baseline and within −20/100 of baseline.
Results: CPM hypoalgesia, when defined as a reduction in pain levels >10/100, did not last longer 
following the more intense 7°C CPT compared to the 12°C CPT (32 min vs. 20 min, respectively; P = 
0.06); similar results were obtained when CPM hypoalgesia was defined as a reduction in pain levels of >20/ 
100 (16 min following the 7°C CPT vs. 9 min following the 12°C CPT; P = 0.33). The duration of CPM 
hypoalgesia was significantly longer when the 10/100 threshold was used compared to the 20/100 
threshold, regardless of CPT temperature (P = 0.008 for the 12°C CPT; P < 0.001 for the 7°C CPT).
Conclusions: The more intense CS did not induce CPM hypoalgesia of longer duration compared to 
the less intense CS. The choice of threshold for what constitutes CPM hypoalgesia did have 
a significant effect on the results.
RÉSUMÉ
Contexte: L’ampleur et la durée de la modulation de la douleur conditionnée (MDC) dépendent 
probablement de la nature et de l’intensité du stimulus de conditionnement.
Objectifs: Le but de cette étude était de mesurer l’effet de l’intensité du stimulus de conditionne-
ment sur la durée de l’hypoalgésie par MDC.
Méthodes: Dans cette étude en simple aveugle, non randomisée, à mesures répétées, nous avons 
évalué l’hypoalgésie par MDC chez 20 participants en bonne santé à la suite de tests au froid à 7 ° C 
et 12 ° C. Le stimulus du test, une stimulation thermique de 60 secondes, a été administré avant le 
test au froid et immédiatement après, puis à nouveau à des intervalles de cinq minutes jusqu’à ce 
que les scores de douleur des participants reviennent aux niveaux antérieurs au stimulus de 
conditionnement.
Deux seuils d’hypoalgésie ont été utilisés pour établir le retour au niveau antérieur au stimulus 
de conditionnement : à l’intérieur de - 10 / 100 de la situation de départ et à l’intérieur de - 20 / 100 
de la situation de départ.
Résultats: L’hypoalgésie par MDC, définie comme une réduction des niveaux de douleur > 10 / 100, 
n’a pas duré plus longtemps après le test au froid plus intense de 7 ° C que le test au froid de 12 ° C 
(32 minutes comparativement à 20 minutes, respectivement ; P = 0,06) ; des résultats similaires ont 
été obtenus lorsque l’hypoalgésie par MDC était définie comme une réduction des niveaux de 
douleur > 20 / 100 (16 minutes après le test au froid à 7 ° C comparativement à 9 minutes après le 
test au froid à 12 ° C ; P = 0,33).
La durée de l’hypoalgésie par MDC était significativement plus longue lorsque le seuil 10 / 100 
était utilisé comparativement au seuil 20 / 100, quelle que soit la température du test au froid (P = 
0,008 pour le test au froid à 12 ° C ; P < 0,001 pour le test au froid à 7 ° C).
Conclusions: Le stimulus de conditionnement plus intense n’a pas induit d’hypoalgésie par MDC de 
plus longue durée comparativement au stimulus de conditionnement moins intense. Le choix du 
seuil pour ce qui constitue une hypoalgésie par MDC a eu un effet significatif sur les résultats.
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Introduction
Pain perception is modulated by various intrinsic 
mechanisms, such as the diffuse noxious inhibitory con-
trols described in animal models by Le Bars et al.,1 
wherein a noxious stimulus induces widespread hypoal-
gesia. This phenomenon is studied in humans under the 
umbrella term “conditioned pain modulation” (CPM),2 
and its dysfunction has been implicated in the develop-
ment, maintenance, and exacerbation of many chronic 
pain conditions,3 including fibromyalgia, osteoarthritis, 
irritable bowel syndrome, temporomandibular disorder, 
and atypical trigeminal neuralgia.4–8 CPM response can 
be hyperalgesic (i.e., resulting in more intense pain sen-
sations) or hypoalgesic (i.e., resulting in milder pain 
sensations); a hypoalgesic response is more common3 
and is the focus of the present study.
CPM response can be influenced by a number of 
biopsychosocial factors (for a review, see Lewis et al.3). 
For instance, men generally show greater CPM hypoal-
gesia compared to women,4,9,10 and patients suffering 
from chronic pain tend to show milder and shorter CPM 
hypoalgesia3 compared to healthy subjects.11 CPM is 
also influenced by pain catastrophizing9 and by expecta-
tions of pain arising from suggestions or beliefs.12–15
CPM can also be affected by the characteristics of the 
triggering noxious stimulus, also known as the condi-
tioning stimulus (CS).16,17 More specifically, it appears 
that the intensity and/or the nature of the CS could affect 
the magnitude and/or the duration of the CPM response; 
however, the relationships between these variables have 
not been systematically studied, and the evidence on 
hand is rather sparse and heterogeneous. It does seem 
that the magnitude of CPM hypoalgesia can be affected 
both by the intensity of the CS18–21 and by its nature (i.e., 
type of painful stimulus).22–25 Indeed, the magnitude of 
CPM hypoalgesia is generally correlated with CS inten-
sity, where a more intense CS generates more potent 
CPM hypoalgesia14; moreover, a recent study has shown 
that three different types of CS (cold pressor test [CPT], 
cuff pressure pain stimulation, and thermode-based cold 
pain stimulation), all calibrated to induce pain rated at 
55 ± 5/100, reduced the intensity of perceived pain by 
43%, 25%, and 23%, respectively.25 The duration of 
CPM hypoalgesia has also been investigated, with 
authors reporting hypoalgesia lasting up to 10 min26 
and 30 min26; unfortunately, these two studies were 
too heterogeneous to determine whether variations in 
the duration of CPM hypoalgesia were attributable to CS 
type, CS intensity, or a combination of both.
The aim of our study was to assess the effect of CS 
intensity on the duration of CPM hypoalgesia; more 
specifically, we wanted to determine whether a 7°C 
CPT (i.e., a cold-water bath) would induce longer- 
lasting CPM hypoalgesia compared to a 12°C CPT. 
Our hypothesis was that the more intense CS (7°C 
CPT) would result in a CPM hypoalgesia of longer 
duration than the less intense CS.
Methods
Participants
We recruited 20 healthy subjects aged 18 to 45 years old, 
suffering from no known diseases and not regularly tak-
ing pain medication. The study had a crossover design, 
with all participants undergoing the two experimental 
conditions. We requested that participants not take 
short term over-the-counter painkillers, such as ibupro-
fen, during the 24 h leading up to the two experimental 
visits and that they not ingest more than their usual dose 
of caffeine3 on the day of the experiment (we did not ask 
them to forgo caffeine entirely, to avoid potential with-
drawal headaches). The procedure took place at the 
Centre de recherche du Centre hospitalier universitaire 
de Sherbrooke, Sherbrooke, Québec, Canada. Written 
informed consent was obtained from all participants, 
and the study was conducted in accordance with the 
Declaration of Helsinki and was approved by the ethics 
review board of the Centre de recherche du Centre 
hospitalier universitaire de Sherbrooke (ethics approval 
number 05-021-M9).
Experimental Procedure
Testing Sequence and Apparatus
We used a CPM testing procedure inspired by that of 
Yarnitsky et al.,2 described in our previously published 
studies,21,27,28 wherein a test stimulus (TS) is applied 
before and after a CS. CPM is measured as the difference 
in pain levels elicited by the TS before and after the CS. 
The time of day at which participants were tested differed 
among participants, but for each participant both sessions 
took place at the same time of day. The TS was generated 
by a 3 × 3 cm thermode (TSA II, NeuroSensory Analyzer, 
Medoc Instruments, Durham, NC), applied on the right 
forearm of participants. Pain perception was assessed 
with a computerized visual analog scale (CoVAS) with 
the left boundary identified as no pain (score = 0) and the 
right boundary as intolerable pain (score = 100). Pretests 
were conducted wherein the thermode temperature was 
gradually increased; participants were instructed to start 
moving the cursor toward the right when the heat sensa-
tion became painful and that it should reach the right 
boundary when the pain became intolerable. Results from 
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these pretests were used to identify the Pain50 tempera-
ture (i.e., the temperature evoking a pain sensation rated 
as 50/100) for every participant, which was used for all 
formal TS.21,29,30 The CS consisted of a CPT at 12°C or 7° 
C. The CPT is considered a reliable method to activate 
CPM hypoalgesia23,31,32 and has been shown to reduce TS 
pain ratings by up to 40%.21 The 12°C and 7°C tempera-
tures were chosen because they had previously been 
shown to induce short-term CPM hypoalgesia of different 
magnitudes.21
Pre-CS Test Stimulus (T0)
Our TS consisted of a noxious heat stimulus generated by 
the thermode applied for 60 s on the anterior right fore-
arm at the predetermined Pain50 temperature. Subjects 
were told that the thermode temperature could increase, 
remain stable, or decrease over the course of the stimula-
tion and that they should record their level of pain 
throughout the test using the CoVAS. In fact, after 
a constant rise (0.3°C/s) from baseline (32°C) to the 
predetermined temperature, the thermode temperature 
remained fixed throughout the TS (60 s total). The aver-
age pain score over the 60-s stimulation was computed, 
and this score (i.e., the pre-CS TS score) was used for 
comparison with post-CS measurements.
Conditioning Stimulus
The CS consisted of a CPT, wherein participants 
immersed their left arm in cold water for 2 min. The 
CPT was administered within the minute following the 
pre-CS TS. The pain levels elicited by the CPT were 
recorded every 15 s using the CoVAS. Subjects who 
could not bear to hold their arm in cold water for the 
full 2 min were automatically given a score of 100/100.33,34 
Each participant completed the procedure twice: on day 1 
with the CPT at 12°C and on day 2 with the CPT at 7°C. 
Participants, but not researchers, were blinded to CPT 
temperatures.
Post-CS Test Stimulus (T1, T2, . . ., Tn)
The TS was re-administered at regular intervals following 
the CS, so that the duration of CPM hypoalgesia could be 
assessed. The first post-CS TS was administered immedi-
ately (within 1 min) after the CS and subsequently 
repeated at 5-min intervals; in other words, establishing 
time 0 as the end of the CS, post-CS TS were administered 
at t ≈ 0 min, t = 5 min, t = 10 min, t = 15 min, etc., until 
pain ratings returned within 10/100 of pre-CPT levels for 
two consecutive measurements (see data analysis for 
more details). Each post-CS TS was identical to the pre- 
CS TS, except that the exact location of the thermode was 
slightly modified for each post-CS TS to avoid sensitiza-
tion. As with the pre-CS TS, pain ratings were 
continuously recorded on the CoVAS throughout the 
duration of the post-CS TS. The pain ratings obtained 
throughout each TS were averaged to yield a single pain 
score for each post-CS TS, and this score was used for 
comparison with the pre-CS TS score.
Data Analysis
Duration of CPM Hypoalgesia
CPM was measured by comparing the levels of pain 
elicited by the thermode before and after the CS. That 
is, for each post-CS measurement, we calculated the dif-
ference between the pre-CS TS score and the post-CS TS 
score, such that a positive value indicated a reduction in 
pain perception (i.e., hypoalgesia). We set the threshold 
for CPM hypoalgesia at 10/100,35 such that participants 
showing a pain reduction ≥10/100 were considered to 
show CPM hypoalgesia. A single score below threshold 
was not sufficient to assume cessation of CPM hypoalge-
sia; participants with a single subthreshold score were still 
considered to be showing CPM hypoalgesia provided that 
they met this threshold again at the subsequent measure-
ment. Participants were no longer considered to show 
CPM hypoalgesia when their hypoalgesia scores failed to 
meet the threshold for two consecutive measurements, 
and the duration of their CPM hypoalgesia was registered 
as the last sample time when hypoalgesia was observed 
(for example, if a participant showed hypoalgesia at 
t = 10 min but not at t = 15 min or at t = 20 min, we 
considered that CPM hypoalgesia had been present for 
10 min). We also re-analyzed the data, using a more 
conservative threshold for CPM hypoalgesia set at 20/100.
Statistical Analysis
Because of the small number of subjects (n < 30) and 
because visual inspection of the histograms did not allow 
us to assume that the data were normally distributed, all 
statistical tests used were nonparametric. Sample size 
was not calculated a priori, because we did not have 
access to similar studies whose results and effect size 
could have informed such sample size calculations. The 
duration of CPM hypoalgesia was defined for each par-
ticipant as outlined in the section above, and the scores 
were averaged to obtain a mean duration of CPM 
hypoalgesia for the two conditions (7°C CPT and 12°C 
CPT). The averages were compared using the Wilcoxon 
signed-rank test. The same test was used to compare, 
within each condition, the average duration of CPM 
hypoalgesia that was obtained using the two hypoalgesia 
thresholds (see above). Finally, as part of a post hoc, 
exploratory analysis, we assessed the correlation 
between the duration and magnitude of of CPM hypoal-
gesia (using the magnitude of CPM hypoalgesia 
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immediately post-CS and 5 min post-CS) using 
Spearman’s rank correlation coefficient. All tests were 
performed using SPSS (version 17.0 for Windows; SPSS 
Inc., Chicago, IL). The threshold for statistical signifi-
cance was set at P < 0.05.
Results
Participants and Missing Data
Our sample consisted of 20 volunteers (10 men and 10 
women), aged 24.8 ± 3.5 years old. One participant only 
tolerated 90 s of immersion during the 7°C CPT; all others 
were able to tolerate both CPTs for the whole duration 
(120 s) of the immersion. The 7°C CPT, which induced an 
average pain rating of 62 ± 19/100, was, as expected, 
significantly more painful than the 12°C CPT, which 
induced an average pain rating of 39 ± 20/100 (P < 0.001).
For technological reasons, we were unable to record 
some post-CS TS pain scores. Altogether, between our 
20 participants undergoing the experiment twice and 
pain ratings being collected every 5 min until they failed 
to show hypoalgesia for two consecutive measurements, 
we ended up with a total of 8.7% missing data (35 out of 
404 data points). We elected to linearly interpolate the 
missing data using immediately adjacent scores.
Duration of CPM Hypoalgesia
The number of participants showing CPM hypoalgesia 
at every post-CS TS measurement is shown in Figure 1. 
The longest duration of hypoalgesia observed in both 
conditions is also shown in this figure, represented as the 
Figure 1. Number of participants exhibiting CPM hypoalgesia at each sampling time following the 12°C and 7°C CPT. Data obtained 
using the threshold for hypoalgesia of (a) ≥20/100 and (b) ≥10/100. CPT indicates cold pressor test; CPM, conditioned pain modulation.
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last sampling time with at least one participant still 
showing CPM hypoalgesia. Following the less intense 
CS (12°C CPT), the longest duration of CPM hypoalge-
sia observed was 75 min with the ≥10/100 threshold and 
45 min with the ≥20/100 threshold; following the more 
intense CS (7°C CPT), the longest duration of CPM 
hypoalgesia was 115 and 105 min, respectively, depend-
ing on the threshold.
The mean duration of CPM hypoalgesia following the 
12°C CPT and the 7°C CPT, obtained using the two 
thresholds (≥10 and ≥20), is reported in Table 1. CPM 
hypoalgesia duration appeared to be more than 50% 
longer following the 7°C CPT compared to the 12°C 
CPT, but this difference was not statistically significant 
for either threshold (P = 0.06 and P = 0.33, respectively). 
The difference in duration obtained with the two thresh-
olds, on the other hand, was statistically significant (P = 
0.008 for the 12°C CPT and P = 0.001 for the 7°C CPT). 
In other words, though no difference was observed in the 
duration of CPM hypoalgesia following the two different 
CPTs, the choice of threshold had a significant effect on 
the results we obtained.
We assessed the correlation between the magnitude of 
CPM hypoalgesia (at t ≈ 0 min post-CS and t = 5 min 
post-CS) and the duration of CPM hypoalgesia for both 
conditions (12°C CPT and 7°C CPT), under both thresh-
olds (≥10 and ≥20; Table 2). With a single exception 
(12°C CPT under the ≥20 threshold only), the magnitude 
of CPM hypoalgesia at t ≈ 0 min post-CS showed no 
correlation with CPM duration (all Ps > 0.5; all 
Spearman’s ρ < 0.15). In contrast, the magnitude of 
CPM hypoalgesia at t = 5 min post-CS was significantly 
correlated with the duration of CPM hypoalgesia, for 
both conditions and under both thresholds (0.65 ≤ all 
Spearman’s ρ ≤ 0.75; all Ps < 0.002). Scatterplots showing 
individual data for each of the eight correlations calcu-
lated (threshold: 10/100 or 20/100; CPT: 7°C or 12°C; 
time post-CS: ≈ 0 min or 5 min) are presented in 
Supplementary Figure 1a–h.
Discussion
Our results show that the CPM hypoalgesia induced by 
the 7°C CPT did not outlast the CPM hypoalgesia 
induced by the 12°C CPT, which contradicts our initial 
hypothesis. However, these findings should not be 
regarded as strong proof that the duration of CPM 
hypoalgesia is entirely independent of CS intensity, for 
two reasons. First, it is possible that our lack of statistical 
significance is attributable to our low sample size and 
resulting low power. Indeed, our ability to identify 
a difference in the duration of hypoalgesia (calculated as 
1 − β) was 19% when the 20/100 threshold was used and 
40% when the 10/100 threshold was used, very much 
below the standard 80%. Indeed, the difference between 
the average duration of CPM hypoalgesia following the 
12°C CPT and the 7°C CPT is substantial (20 min vs. 
32 min with a ≥10/100 threshold), and though the asso-
ciated P value is not statistically significant (P = 0.06), it is 
close enough to the significance threshold that a larger 
sample may have yielded significant results. We therefore 
recommend that future researchers use our results to 
calculate an appropriate sample size to have enough 
power to detect an effect, if there is one to be found. 
Moreover, we failed to randomize the two experimental 
conditions, which may have resulted in an order effect 
(we did, however, ensure that the participants were naïve 
to the CPT temperatures). As such, though our results do 
not support the hypothesis that CS intensity affects CPM 
hypoalgesia duration, they do not strongly refute it either. 
Nevertheless, as they stand, our results can be of some 
comfort to future CPM study participants: indeed, it 
appears that undergoing the painful 7°C CPT might not 
be required: the 12°C CPT seems just as apt at trigger-
ing CPM.
As we have previously mentioned, various studies on 
CPM have reported different CPM durations,26,36 which 
suggests that CPM is not an all-or-nothing phenomenon 
and that some variables (including characteristics of the 
participants, such as age, sex, etc., and characteristics of 
Table 1. Mean duration of hypoalgesia following the 12°C and 7°C 
CPT.
Mean duration of hypoalgesia (minutes)
12°C CPT 7°C CPT P value
Threshold: 20 9 16 0.332
Threshold: 10 20 32 0.061
P value 0.008 0.001
Duration is in minutes. Results obtained from analysis using the two thresh-
olds for hypoalgesia (pain reduction of ≥20/100 and ≥10/100) are 
presented. 
CPT indicates cold pressor test.
Table 2. Correlation between magnitude and duration of CPM 
hypoalgesia.
Time post-CS CPT Threshold Spearman Rs p value
t ≈ 0 min 12°C ≥ 10 0.15 0.53
≥ 20 0.5 0.02
7°C ≥ 10 0.07 0.77
≥ 20 0.11 0.67
t = 5 min 12°C ≥ 10 0.73 <0.001
≥ 20 0.68 0.001
7°C ≥ 10 0.65 0.002
≥ 20 0.72 <0.001
The correlations were calculated for both conditions (12°C CPT and 7°C CPT), 
for all combinations of CPM hypoalgesia scores (taken immediately post-CS 
or at t = 5 min post-CS) and duration scores (calculated with a ≥10 or ≥20 
hypoalgesia threshold). 
CPM indicates conditioned pain modulation; CS, conditioning stimulus; CPT, 
cold pressor test.
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the CS3,26,36) affect CPM duration. However, CPM dura-
tion remains, in our opinion, understudied: to the best of 
our knowledge, we are the first team to systematically 
study the effect of CS intensity on the duration of CPM 
hypoalgesia, despite the fact that the duration of CPM 
hypoalgesia is a variable relevant to both fundamental 
and clinical research. Indeed, understanding the factors 
influencing the variability in the duration of CPM hypoal-
gesia could help shed light on the neurophysiological 
mechanisms underlying CPM hypoalgesia; a better 
understanding of normal processes would in turn allow 
for a better understanding of their dysfunction, such as is 
seen in chronic pain conditions. For example, though it 
has been established that many patients suffering from 
chronic pain show milder CPM hypoalgesia,3–8 the dura-
tion of CPM hypoalgesia has seldom been studied in this 
population, and it is entirely plausible that they exhibit 
CPM hypoalgesia that is not only milder but also of 
shorter duration, which could in turn partly explain 
their clinical features. Of course, these are only specula-
tions, and further studies should be undertaken to prop-
erly assess the effect of CS intensity on the duration of 
CPM hypoalgesia. Interestingly, our results show 
a moderate correlation between the magnitude and dura-
tion of CPM hypoalgesia 5 min post-CS but not imme-
diately post-CS. The implications of these results are 
twofold: first, the correlation between the duration and 
magnitude of CPM hypoalgesia 5 min post-CS indicates 
that clinicians and researchers may be able to infer valu-
able (if not perfectly accurate) information regarding 
their patient’s or participant’s CPM hypoalgesia duration 
simply by measuring its magnitude, thereby allowing 
them to forgo the tedious and resource-consuming 
2-h-long testing session that would otherwise be 
requiered to assess CPM duration. Second, the absence 
of correlation obtained between the magnitude and dura-
tion of CPM hypoalgesia when CPM magnitude is mea-
sured immediately post-CS suggests that CPM response is 
initially noisy and stabilizes over the course of a few 
minutes post-CS. The source of this initial fluctuation 
has yet to be determined: it could stem from a residual 
distraction of having one’s arm dunked in cold water, or 
from the time required for the physiological processes 
underlying CPM to get fully underway, or from some-
thing else entirely. In any case, it follows from our results 
that waiting a few minutes post-CS to measure CPM may 
yield more reliable information regarding CPM response 
compared to measuring CPM immediately following the 
CS. However, these results should be taken with caution, 
because our small sample size and the relatively high 
proportion of participants with a small and short-lived 
CPM response may increase the extent to which these 
correlations are driven by outliers.
A incidental finding or our study concerns the choice 
of hypoalgesia threshold (10/100 vs. 20/100), which 
turned out to have a statistically significant effect on 
the results. And though this is entirely intuitive, the 
ramifications are worth considering. Indeed, many stu-
dies on pain require that a significance threshold be set. 
The typical conservative threshold of 20/100 is well 
accepted for clinical significance,37 although some 
authors have argued for the use of a 15/100 threshold 
in certain populations, notably the elderly,38 and others 
advocate the need for a rather more conservative thresh-
old, such as 30% or even 50%.39 However, it may be that 
different thresholds are appropriate depending on the 
research context. Indeed, if one’s goal is to assess 
whether an intervention can decrease pain levels in 
a patient population in a way that is clinically mean-
ingful and outweighs the costs of treatment, then per-
haps a threshold of 20/100 or more would be preferable. 
However, if one’s goal is to gain a better understanding 
of the neurophysiological mechanisms underlying pain 
modulation, perhaps a pain reduction of 10/100 is large 
enough to denote a physiologically meaningful effect. 
Researchers should therefore choose their threshold 
carefully, keeping in mind both the context of their 
study and the dramatic effect that the choice of threshold 
can have on effect size and the ability to detect changes.
Conclusion
Our results do not support the hypothesis that increas-
ing CS intensity increases the duration of CPM hypoal-
gesia. CPM hypoalgesia, when defined as a reduction 
of pain levels of 10/100 or more, lasted on average 
32 min following the 7°C CPT and 20 min following 
the 12°C CPT, with no statistical difference in duration 
between the two conditions. However, readers should 
keep in mind that our sample size was small and our 
conditions were not randomized; additional, high- 
powered research will be required to draw robust con-
clusions. Our results also show that the choice of 
threshold has a nonnegligible impact on results, 
which highlights the importance of choosing this 
threshold carefully, keeping in mind the study context 
(clinical vs. mechanistic).
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